Miyazaki K, Horie K, Watanabe H, Hidaka R, Hayashi R, Hayatsu N
Genes Dev. 2025; 39(5-6):384-400.
PMID: 39904558
PMC: 11874989.
DOI: 10.1101/gad.352111.124.
Wang Y, Li D, Liu Y, Chen S, Dong Z
Sci Adv. 2025; 11(2):eadp9894.
PMID: 39792675
PMC: 11721569.
DOI: 10.1126/sciadv.adp9894.
Hassouneh Z, Huang G, Zhang N, Rao M, Mukherjee N
J Cancer Immunol (Wilmington). 2024; 6(3):125-134.
PMID: 39574565
PMC: 11580033.
DOI: 10.33696/cancerimmunol.6.093.
Mangani D, Subramanian A, Huang L, Cheng H, Krovi S, Wu Y
Immunity. 2024; 57(11):2565-2582.e6.
PMID: 39447575
PMC: 11614491.
DOI: 10.1016/j.immuni.2024.09.017.
Markowitz G, Ban Y, Tavarez D, Yoffe L, Podaza E, He Y
Nat Immunol. 2024; 25(10):1884-1899.
PMID: 39327500
DOI: 10.1038/s41590-024-01963-1.
Recipient tissue microenvironment determines developmental path of intestinal innate lymphoid progenitors.
Clark P, Gogoi M, Rodriguez-Rodriguez N, Ferreira A, Murphy J, Walker J
Nat Commun. 2024; 15(1):7809.
PMID: 39242588
PMC: 11379955.
DOI: 10.1038/s41467-024-52155-2.
Stem-like T cells are associated with the pathogenesis of ulcerative colitis in humans.
Li Y, Ramirez-Suastegui C, Harris R, Castaneda-Castro F, Ascui G, Perez-Jeldres T
Nat Immunol. 2024; 25(7):1231-1244.
PMID: 38898157
PMC: 11800318.
DOI: 10.1038/s41590-024-01860-7.
Distinct developmental pathways generate functionally distinct populations of natural killer cells.
Ding Y, Lavaert M, Grassmann S, Band V, Chi L, Das A
Nat Immunol. 2024; 25(7):1183-1192.
PMID: 38872000
DOI: 10.1038/s41590-024-01865-2.
Eomes expression identifies the early bone marrow precursor to classical NK cells.
Liang Z, Anderson H, Locher V, OLeary C, Riesenfeld S, Jabri B
Nat Immunol. 2024; 25(7):1172-1182.
PMID: 38871999
PMC: 11409033.
DOI: 10.1038/s41590-024-01861-6.
Elusive early NK cell progenitor identified.
Patey E, Bjorkstrom N
Nat Immunol. 2024; 25(7):1126-1128.
PMID: 38871998
DOI: 10.1038/s41590-024-01871-4.
Transcription factor Tox2 is required for metabolic adaptation and tissue residency of ILC3 in the gut.
Das A, Martinez-Ruiz G, Bouladoux N, Stacy A, Moraly J, Vega-Sendino M
Immunity. 2024; 57(5):1019-1036.e9.
PMID: 38677292
PMC: 11096055.
DOI: 10.1016/j.immuni.2024.04.001.
Group 1 ILCs: Heterogeneity, plasticity, and transcriptional regulation.
Sudan R, Gilfillan S, Colonna M
Immunol Rev. 2024; 323(1):107-117.
PMID: 38563448
PMC: 11102297.
DOI: 10.1111/imr.13327.
Dysregulation of Wnt/β-catenin signaling contributes to intestinal inflammation through regulation of group 3 innate lymphoid cells.
Hao J, Liu C, Gu Z, Yang X, Lan X, Guo X
Nat Commun. 2024; 15(1):2820.
PMID: 38561332
PMC: 10985070.
DOI: 10.1038/s41467-024-45616-1.
Circulating NK cells establish tissue residency upon acute infection of skin and mediate accelerated effector responses to secondary infection.
Torcellan T, Friedrich C, Doucet-Ladeveze R, Ossner T, Sole V, Riedmann S
Immunity. 2023; 57(1):124-140.e7.
PMID: 38157853
PMC: 10783803.
DOI: 10.1016/j.immuni.2023.11.018.
Effector-Phase IL-2 Signals Drive Th1 Effector and Memory Responses Dependently and Independently of TCF-1.
Charley K, Ramstead A, Matous J, Kumaki Y, Sircy L, Hale J
J Immunol. 2023; 212(4):586-595.
PMID: 38149929
PMC: 10872735.
DOI: 10.4049/jimmunol.2300570.
Bcl6 is a subset-defining transcription factor of lymphoid tissue inducer-like ILC3.
Tacho-Pinot R, Stamper C, King J, Matei-Rascu V, Richardson E, Li Z
Cell Rep. 2023; 42(11):113425.
PMID: 37950867
PMC: 7615641.
DOI: 10.1016/j.celrep.2023.113425.
Regulatory ILC2-Role of IL-10 Producing ILC2 in Asthma.
Fard N, Xiao M, Sehmi R
Cells. 2023; 12(21).
PMID: 37947634
PMC: 10650705.
DOI: 10.3390/cells12212556.
Both Horatio and Polonius: Innate Lymphoid Cells in Tissue Homeostasis and Repair.
Lee I, Van Dyken S
Immunohorizons. 2023; 7(11):729-736.
PMID: 37916861
PMC: 10695417.
DOI: 10.4049/immunohorizons.2300053.
Nr4a1 marks a distinctive ILC2 activation subset in the mouse inflammatory lung.
Xu S, Zhang Y, Liu X, Liu H, Zou X, Zhang L
BMC Biol. 2023; 21(1):218.
PMID: 37833706
PMC: 10576290.
DOI: 10.1186/s12915-023-01690-3.
Tumor immunogenicity dictates reliance on TCF1 in CD8 T cells for response to immunotherapy.
Escobar G, Tooley K, Oliveras J, Huang L, Cheng H, Bookstaver M
Cancer Cell. 2023; 41(9):1662-1679.e7.
PMID: 37625402
PMC: 10529353.
DOI: 10.1016/j.ccell.2023.08.001.